China’s State Food and Drug Administration (SFDA) has recently issued various laws to regulate more stringently quality control in the medical market. The US Department of Health and Human Services (HHS) is also helping China improve its medical market. The HHS and... Read More
The Medical Device Product Working Group of the ASEAN Consultative Committee for Standards and Quality held a meeting from July 30 to August 2, 2007 to discus various topics and strategies to increase harmonization of medical device regulations across the ASEAN countries.... Read More
The Indonesian Health Minister has set a deadline of August 2006 for full compliance with a ministerial decree regarding drug labeling requirements. Ministerial Decree 68/2006 requires drug companies to print generic names and retail prices on packaging for all branded drugs. The... Read More
Japan’s new Pharmaceutical Affairs Law (PAL), effective as of April 1, 2005, outlines the new post-marketing safety measures, also known as Good Vigilance Practice (GVP). This regulation clarifies the responsibilities of distributors of medical devices, drugs, quasi-drugs, and cosmetic products. All Marketing... Read More
The healthcare industry in Malaysia is currently valued at around $1 billion and growing at a steady rate of 6-8 percent annually. The country still imports more than half of its pharmaceuticals and medical equipment, with the U.S., Japan and Germany as... Read More
The Thai Food and Drug Administration (FDA), under the Ministry of Public Health (MOPH), is responsible for protecting the health of consumers by ensuring the safety, quality and efficacy of health products, including food, pharmaceuticals, medical devices and cosmetics, in Thailand. The... Read More
In an effort to prevent and reduce errors in administering medication, Taiwan’s Legislative Yuan (Council) ratified a revision of the Pharmacy Law on January, 14, 2003, requiring that all medicines sold in Taiwan must have labels in Chinese. Due to increased instances... Read More